<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Basic principles and technique of bronchoalveolar lavage
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Basic principles and technique of bronchoalveolar lavage
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Basic principles and technique of bronchoalveolar lavage
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Talmadge E King, Jr, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kevin R Flaherty, MD, MS
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Henri G Colt, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Paul Dieffenbach, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 20, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bronchoalveolar lavage (BAL), performed during flexible bronchoscopy, has gained widespread acceptance as a minimally invasive method that provides important information about immunologic, inflammatory, and infectious processes taking place at the alveolar level [
         <a href="#rid1">
          1
         </a>
         ]. Studies comparing BAL cellular constituents to cells obtained from open lung biopsy have shown that the cell types and their state of activation are similar with either collection method.
        </p>
        <p>
         This review will consider the basic principles and technique of BAL. The utility of this procedure in individual diseases is discussed in the appropriate topic reviews. The use of preprocedure medication, topical anesthesia of the upper airway, and techniques for the passage of the bronchoscope into the lung are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/4398.html" rel="external">
          "Flexible bronchoscopy in adults: Overview"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4400.html" rel="external">
          "Flexible bronchoscopy in adults: Indications and contraindications"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/105799.html" rel="external">
          "Flexible bronchoscopy in adults: Preparation, procedural technique, and complications"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/106085.html" rel="external">
          "Flexible bronchoscopy in adults: Associated diagnostic and therapeutic procedures"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          PATIENT SELECTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bronchoalveolar lavage (BAL) has been widely used in patients with a variety of lung diseases [
         <a href="#rid2">
          2
         </a>
         ]. Advantages with this technique include its noninvasive nature and ability to readily sample alveolar contents.
        </p>
        <p>
         As a result, it has an important role in management of diffuse lung diseases for the following reasons [
         <a href="#rid3">
          3,4
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         It is an excellent method to obtain specimens to rule out opportunistic infections in immunocompromised hosts [
         <a href="#rid5">
          5
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         It can provide clues to the correct diagnosis of certain diseases (eg, acute eosinophilic pneumonia and diffuse alveolar hemorrhage) (see
         <a class="medical medical_review" href="/z/d/html/4374.html" rel="external">
          "Idiopathic acute eosinophilic pneumonia"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4341.html" rel="external">
          "The diffuse alveolar hemorrhage syndromes"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In some cases, it permits assessment of the stage of disease and potential responsiveness to therapy
        </p>
        <p>
        </p>
        <p>
         There are no absolute contraindications to the performance of BAL beyond those commonly associated with bronchoscopy  (
         <a class="graphic graphic_table graphicRef79205" href="/z/d/graphic/79205.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid6">
          6,7
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4400.html" rel="external">
          "Flexible bronchoscopy in adults: Indications and contraindications"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          TECHNIQUE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bronchoalveolar lavage (BAL) is performed following general inspection of the tracheobronchial tree and before biopsy or brushing [
         <a href="#rid8">
          8
         </a>
         ]. This sequence minimizes the likelihood that iatrogenic bleeding will alter the concentration of cellular and protein components. The usual procedures for patient preparation, sedation, and monitoring for flexible bronchoscopy should be followed. (See
         <a class="medical medical_review" href="/z/d/html/105799.html" rel="external">
          "Flexible bronchoscopy in adults: Preparation, procedural technique, and complications"
         </a>
         .)
        </p>
        <p>
         BAL differs from bronchial washings, in which secretions are aspirated from large airways directly or following the instillation of 10 to 30 mL of
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         .
        </p>
        <p>
         Whole lung lavage is a different procedure that is uniquely used as therapy for pulmonary alveolar proteinosis; 30 to 50 liters of sterile
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         are delivered via a double lumen endotracheal tube under general anesthesia. (See
         <a class="medical medical_review" href="/z/d/html/4373.html" rel="external">
          "Causes, clinical manifestations, and diagnosis of pulmonary alveolar proteinosis in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Optimal site
         </span>
         <span class="headingEndMark">
          —
         </span>
         Little information exists regarding the optimal site in the lung for BAL, although a good general rule is to perform the lavage where the disease is most prominent radiographically [
         <a href="#rid8">
          8
         </a>
         ]. In localized disease, lavage of the involved segment is more likely to yield the best results. In diffuse disease, the right middle lobe or lingula is lavaged most commonly because, when the patient is supine, the anatomy favors maximal recovery of fluid and cells from these sites. If anatomic or technical difficulties are encountered, either the superior or anterior segment of a lower lobe may be used.
        </p>
        <p>
         Lavage in one site is usually adequate, especially if a cumulative volume of 100 mL or greater is instilled. A lavage volume of 100 mL samples approximately one million alveoli (1.5 to 3 percent of the lung). It is thought that such a sample provides a representative picture of the inflammatory and immune processes in the alveoli regardless of the site of the lavage [
         <a href="#rid9">
          9
         </a>
         ]. Nevertheless, some centers routinely instill 100 mL of fluid into each of two or three different areas. Such an approach may be particularly useful when there is marked radiographic heterogeneity in the disease process. The lavage site(s) should always be recorded in the bronchoscopy report.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Fluid instillation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Once the lavage site has been chosen, the bronchoscope is advanced into a subsegmental bronchus until the lumen is occluded; this is referred to as the "wedged" position. Care must be taken to avoid "over wedging" the bronchoscope, since this can result in additional trauma to the airway and diminish fluid recovery. A good wedge position is usually confirmed by noting slight airway collapse when gentle suction is applied. A poor wedge position allows leakage of lavage fluid around the bronchoscope, leading to cough soon after the fluid is instilled. Optimum fluid recovery occurs when the bronchoscope completely occludes the bronchial lumen of a third or fourth bronchial subsegment  (
         <a class="graphic graphic_figure graphicRef66569" href="/z/d/graphic/66569.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
         Sterile buffered or unbuffered
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         (commercial 0.9 percent NaCl without additives for intravenous use) is used as the instillate. Prewarming the lavage fluid to 37ºC has been suggested to decrease coughing and to increase the cellular yield, but most groups continue to use room temperature saline.
        </p>
        <p>
         The total volume of fluid to be instilled has not been standardized. BAL typically involves the delivery of a total of 100 to 240 mL of fluid in 20 to 60 mL aliquots; larger volumes are occasionally used for research purposes. We usually use two to three sequential aliquots of 40 to 60 mL each.
        </p>
        <p>
         Using tubing with an inline clamp or three way stopcock, a saline-filled, 50 to 60 mL syringe is attached to the side port of the bronchoscope. The first aliquot of
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         is instilled slowly and steadily [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Fluid recovery
         </span>
         <span class="headingEndMark">
          —
         </span>
         After the first aliquot of
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         is infused, it is recovered immediately into the same syringe by gentle continuous hand suction [
         <a href="#rid2">
          2,11
         </a>
         ]. Suction should be gentle enough that visible airway collapse does not occur. In patients with marked airway collapse despite gentle suction, the suctioning process should be slower, and discontinuous suction should be used to maximize fluid retrieval. When no further fluid can be aspirated, the clamp or stopcock is closed and the syringe (but not the tubing) is removed. The second saline filled syringe is attached to the tubing and the procedure is repeated. Following these steps, a third lavage is completed, if desired.
        </p>
        <p>
         In patients with suspected alveolar hemorrhage, three sequential lavages are performed at the same site. The recovered samples are visually inspected for any increase in hemorrhagic appearance from the first syringe to the third. (See
         <a class="medical medical_review" href="/z/d/html/4341.html" rel="external">
          "The diffuse alveolar hemorrhage syndromes"
         </a>
         .)
        </p>
        <p>
         There is no established
         <strong>
          dwell time
         </strong>
         for the fluid to remain before it is suctioned back. We feel that the cellular and noncellular yield is improved by having the patient take several breaths before the fluid is retrieved, though some have raised concern about breaking the wedged position by adding this step. The total duration of lavage after wedging the bronchoscope should take approximately 5 to 10 minutes.
        </p>
        <p>
         Lavage fluid recovery is influenced by several factors [
         <a href="#rid12">
          12
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         It increases with larger volumes instilled. The first aliquot of fluid tends to be poorly recovered (&lt;20 percent); with subsequent aliquots, the return increases, such that 40 to 70 percent of the total instilled volume is recovered.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Small instilled volumes (less than 100 mL) increase the likelihood of contamination of lavage fluid by mucus and large airway cells, rather than sampling of distal (alveolar) sites.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A history of current or past smoking or the presence of chronic obstructive pulmonary disease (COPD) significantly decreases the fluid recovery rate [
         <a href="#rid13">
          13
         </a>
         ]. The average BAL fluid recovery in normal healthy nonsmokers is between 50 to 80 percent of the instilled volume, compared with recovery as low as 20 to 30 percent in otherwise healthy smokers.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fluid recovery decreases with increasing age.
        </p>
        <p>
        </p>
        <p>
         The lavage procedure should be terminated if the instilled volume exceeds recovery by more than 100 mL, or if the patient experiences substantial distress (eg, excessive coughing) or falling oxygen saturation requiring increased oxygen supplementation [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2609379998">
         <span class="h2">
          Monitoring
         </span>
         <span class="headingEndMark">
          —
         </span>
         Flexible bronchoscopy is performed under conscious sedation with monitoring of blood pressure, heart rate, cardiac rhythm, respiratory rate, and pulse oximetry. BAL is rarely complicated by transient hypoxemia due to residual fluid in the alveoli. Thus, all patients should breathe supplemental oxygen during the procedure, titrated to maintain the oxygen saturation above 92 percent. In patients with borderline oxygenation, elective preprocedure intubation and ventilation during the procedure should be considered, as oxygenation will likely deteriorate during the BAL. (See
         <a class="medical medical_review" href="/z/d/html/105799.html" rel="external">
          "Flexible bronchoscopy in adults: Preparation, procedural technique, and complications"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          PROCESSING THE LAVAGE SPECIMEN
         </span>
         <span class="headingEndMark">
          —
         </span>
         The recovered lavage fluid should be pooled into a single container (siliconized glass or non-cell adherent plastic) and the total volume measured. Controversy exists about whether to include the first aliquot of fluid recovered with the remainder; this is more of an issue when the specimen is being processed for cell counts in patients with interstitial lung disease than when evaluating for infection. The first aliquot is usually a small volume and represents a disproportionate amount of bronchial airway material (epithelial cells and neutrophils) compared to alveolar fluid. Our practice is to pool all of the recovered bronchoalveolar lavage (BAL) fluid and to ensure that the pooled fluid is well-mixed.
        </p>
        <p>
         BAL fluid generally should be transported to the laboratory on ice, but can be stored or transported at room temperature if processing will occur in less than one hour. Cells in BAL fluid remain viable for up to four hours when stored at 25°C. In general, BAL samples should be processed immediately for culture; however, storage up to 24 hours at 4°C does not result in loss of diagnostic accuracy of microbiologic culture [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          CELL COUNTING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cell counting of BAL fluid is useful in the evaluation of certain interstitial lung diseases, such as the eosinophilic pneumonias, hypersensitivity pneumonitis, sarcoidosis, and drug-induced lung disease. (See
         <a class="medical medical_review" href="/z/d/html/4308.html" rel="external">
          "Role of bronchoalveolar lavage in diagnosis of interstitial lung disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Initial processing
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of steps are involved in the optimal processing and examination of BAL samples. The lavage fluid frequently contains large amounts of mucus. When cell counts will be performed in the evaluation of interstitial lung disease, filtration of the fluid through sterile cotton gauze or nylon mesh is often performed to prevent the mixing of mucus with the cell pellet after centrifugation; filtration also results in the preferential removal of bronchial epithelial cells. An aliquot of the fluid and cells should be stored in case future testing is required.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Total cell counts
         </span>
         <span class="headingEndMark">
          —
         </span>
         The total number of leukocytes recovered by lavage is determined by examination of a sample of the pooled fluid with a hemocytometer. The cell counts are most accurate when done on the original, pooled sample before any washing procedure has been performed; washing results in a loss of total cells and a decrease in the cell viability.
        </p>
        <p>
         The total white cell count is usually expressed both as the total number of cells recovered per lavage and as the concentration of cells per mL of recovered fluid. Red blood cells and epithelial cells should be enumerated.
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Differential cell counts
         </span>
         <span class="headingEndMark">
          —
         </span>
         Differential cell counts are used to determine whether the patient has an eosinophil or lymphocyte predominant pattern of diffuse lung disease. Cell counts are most frequently determined on slides prepared either by cytocentrifugation or filtration. These procedures are operator-dependent and should be performed by an experienced and properly trained cytotechnologist.
        </p>
        <p>
         With either technique, at least 8 to 10 slides are prepared. The differential counts are performed with a light microscope employing 25x and 40x objectives. Counts are made from random fields of 200 to 500 cells. Esterase staining is often employed to distinguish immature macrophages from large lymphocytes. The number of ciliated or squamous epithelial cells should be noted, but they are not included in the differential count.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cytocentrifugation
         </strong>
         – Cytocentrifugation is the more commonly used method for obtaining a differential cell count; as the name implies, it collects cells by virtue of their outward migration when centrifuged [
         <a href="#rid15">
          15
         </a>
         ]. Differential counting is commonly performed on air-dried (15 to 30 minutes) May-Grunwald-Giemsa or Wright-Giemsa stained preparations. The specimens have less distortion of cell structure and less cell loss (especially the selective loss of lymphocytes) when the "neat" fluid, ie, the original sample before centrifugation and resuspension, is used for the cytocentrifuge preparation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Advantages of this technique include lower cost than filtration methods and the fact that cytocentrifugation slides permit detection of more subtle cytologic features which can occasionally aid diagnosis. Special stains for iron, inorganic dust, malignant cells, and microorganisms may be performed if desired.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Filtration
         </strong>
         – With the filtration method, differential cell counts are performed after trapping cells on a filter. The cells are then stained with hematoxylin and eosin or the modified Papanicolaou technique [
         <a href="#rid16">
          16
         </a>
         ]. This method offers two advantages. First, cell retention by the filter is high, providing a more accurate representation of the cell types and numbers recovered by lavage. Second, these slides can be stored indefinitely without significant loss of cell detail or staining. The major disadvantages of the filter preparations are that they may underestimate the number of neutrophils, and that the method is considerably more time consuming and costly than cytocentrifuge preparation.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Adequacy of BAL
         </span>
         <span class="headingEndMark">
          —
         </span>
         No clear criteria exist for determining the adequacy of the BAL specimen. Unsatisfactory specimens for cell counts for evaluating interstitial lung disease:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Contain fewer than two million total cells
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Have fewer than 10 alveolar macrophages per high power field
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Contain excessive numbers of epithelial cells, either showing morphologic degenerative changes or exceeding the number of alveolar macrophages present
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Contain a mucopurulent exudate of polymorphonuclear cells
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Contain excessive red blood cells due to trauma during the procedure
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Contain degenerative changes or laboratory artifacts obscuring cell identity
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Data expression
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most common method is to present cell differential data in the same manner used for peripheral blood, ie, each white cell type is given as a percentage of the total white cells recovered. The advantage of this method is that it provides the data in a fashion that is familiar. A disadvantage is that the numbers presented are proportions of the total and, as such, changes in the absolute numbers of a single cell line necessarily affect the reported percentages of all cell lines.
        </p>
        <p>
         With the total cell method, the differential is combined with the total cell count to quantify the absolute numbers of each cell type per volume of fluid recovered. The advantage of this method is that it also gives insight into the total number of effector cells present in the alveolar structures. Unfortunately, such quantification is most meaningful if standardized lavage volumes are instilled and recovered. At present, such standardization is not possible, and the differential percentage count of total BAL cells is the more commonly used approach. However, until clear standards are established, both methods should be used and reported by the cytology laboratory.
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Noncellular components of BAL
         </span>
         <span class="headingEndMark">
          —
         </span>
         The usefulness of routine measurement of the noncellular components of BAL in clinical practice remains to be elucidated. It has been extremely difficult to determine what proportion of the fluid recovered by lavage represents alveolar fluid from the distal airways and alveoli, so-called epithelial lining fluid (ELF). Several approaches have been proposed to determine the volume of epithelial lining fluid recovered by BAL, including quantitation of albumin, total lavage protein, potassium,
         <a class="drug drug_general" data-topicid="9636" href="/z/d/drug information/9636.html" rel="external">
          methylene blue
         </a>
         , and urea. However, none of these have become standard practice. In the future, proteomic analysis of ELF may become an attractive method to examine for changes in protein expression and secretion during the course of pulmonary disorders [
         <a href="#rid17">
          17,18
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Lymphocyte subpopulations and immunohistochemistry
         </span>
         <span class="headingEndMark">
          —
         </span>
         Application of immunofluorescent and immunocytochemical techniques to the analysis of cells recovered from BAL is helpful in the diagnosis of certain interstitial lung diseases and pulmonary lymphomas [
         <a href="#rid19">
          19-21
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4308.html" rel="external">
          "Role of bronchoalveolar lavage in diagnosis of interstitial lung disease"
         </a>
         .)
        </p>
        <p>
         Lymphocyte subpopulations (eg, CD3, CD4, CD8) can be assessed using immunofluorescent labeled monoclonal antibodies. After incubation with these antibodies, the cells are passed through a flow cytometer for counting and assessment of polyclonality. The CD4 to CD8 ratio can then be calculated. The advantage of flow cytometry over hand counting of immunohistochemical stained cells on cytocentrifuge prepared slides is the greater number of cells counted by flow cytometry.
        </p>
        <p>
         Flow cytometry can also be used to identify monoclonal populations of lymphocytes that indicate lymphomatous or leukemic infiltrates.
        </p>
        <p>
         When pulmonary Langerhans cell histiocytosis (PLCH) is suspected (middle and upper lung zone predominant nodular and cystic lesions), staining for CD-1a, S-100 protein, or CD207 (langerin) can be diagnostic [
         <a href="#rid22">
          22-24
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4334.html" rel="external">
          "Pulmonary Langerhans cell histiocytosis", section on 'Flexible bronchoscopy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4308.html" rel="external">
          "Role of bronchoalveolar lavage in diagnosis of interstitial lung disease", section on 'Other useful BAL findings'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8385.html" rel="external">
          "Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis", section on 'Pathologic features'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Normal BAL cell counts
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bronchoalveolar lavage (BAL) performed in healthy volunteers has permitted determination of the normal composition of BAL fluid [
         <a href="#rid8">
          8,25,26
         </a>
         ]. The average number of cells recovered in healthy nonsmoking adults ranges from approximately 100 to 150 thousand per mL of lavage fluid recovered. The proportions of the different cell types in normal nonsmoking adults are provided in the table  (
         <a class="graphic graphic_table graphicRef50382" href="/z/d/graphic/50382.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Smoking
         </strong>
         – Smoking increases the number of cells recovered by a factor of four to six, largely due to an increase in the number of macrophages [
         <a href="#rid25">
          25,27
         </a>
         ]. Additional changes in the cell populations are associated with smoking as noted in the tables: never smokers  (
         <a class="graphic graphic_table graphicRef50382" href="/z/d/graphic/50382.html" rel="external">
          table 2
         </a>
         ); former smokers  (
         <a class="graphic graphic_table graphicRef71367" href="/z/d/graphic/71367.html" rel="external">
          table 3
         </a>
         ); and current smokers  (
         <a class="graphic graphic_table graphicRef66165" href="/z/d/graphic/66165.html" rel="external">
          table 4
         </a>
         ) [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h1">
          MICROBIOLOGIC ANALYSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Depending on the clinical situation, samples may be sent for a variety of microbiologic analyses [
         <a href="#rid28">
          28
         </a>
         ]. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Routine qualitative or quantitative bacterial culture (see
         <a class="medical medical_review" href="/z/d/html/1635.html" rel="external">
          "Clinical presentation and diagnostic evaluation of ventilator-associated pneumonia", section on 'Diagnostic evaluation'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Direct fluorescent antigen (DFA) testing for Legionella species (see
         <a class="medical medical_review" href="/z/d/html/7035.html" rel="external">
          "Clinical manifestations and diagnosis of
          <i>
           Legionella
          </i>
          infection"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Legionella culture (see
         <a class="medical medical_review" href="/z/d/html/7035.html" rel="external">
          "Clinical manifestations and diagnosis of
          <i>
           Legionella
          </i>
          infection"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nocardia, actinomycosis, mycobacterial, fungal, and viral culture
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Galactomannan enzyme immunoassay for fungal antigen detection (see
         <a class="medical medical_review" href="/z/d/html/15717.html" rel="external">
          "Diagnosis of invasive aspergillosis", section on 'Bronchoalveolar lavage fluid'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Shell vial immunohistochemical assay or direct staining of bronchoalveolar lavage (BAL) macrophages with monoclonal antibodies for cytomegalovirus pneumonia (see
         <a class="medical medical_review" href="/z/d/html/8291.html" rel="external">
          "Overview of diagnostic tests for cytomegalovirus infection"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fluorescent or silver stain for
         <em>
          Pneumocystis jirovecii
         </em>
         (see
         <a class="medical medical_review" href="/z/d/html/3704.html" rel="external">
          "Epidemiology, clinical presentation, and diagnosis of Pneumocystis pulmonary infection in patients with HIV"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1406.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of Pneumocystis pneumonia in patients without HIV"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Metagenomic next-generation sequencing of BAL fluid has promise as an adjunct to conventional microbiologic tests in the diagnosis of suspected pneumonia, especially in immunocompromised patients [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h1">
          CYTOLOGIC ANALYSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cytologic analysis of bronchoalveolar lavage (BAL) fluid may be helpful in evaluating some lung malignancies (eg, lymphangitic carcinomatosis) and diffuse lung diseases [
         <a href="#rid30">
          30-34
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4308.html" rel="external">
          "Role of bronchoalveolar lavage in diagnosis of interstitial lung disease"
         </a>
         .)
        </p>
        <p>
         After pooling of the total recovered lavage fluid (see
         <a class="local">
          'Processing the lavage specimen'
         </a>
         above), a sample is removed and placed in cytology preservative solution and transported to the cytology laboratory.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Papanicolaou staining is typically used for detecting tumor cells and viral inclusion bodies.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Periodic acid-Schiff (PAS) staining is used to identify PAS-positive lipoproteinaceous material in the distal air spaces and macrophages in pulmonary alveolar proteinosis. (See
         <a class="medical medical_review" href="/z/d/html/4373.html" rel="external">
          "Causes, clinical manifestations, and diagnosis of pulmonary alveolar proteinosis in adults", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prussian blue staining for hemosiderin detects macrophages that have taken up red cells during chronic bleeding, as in diffuse alveolar hemorrhage. When greater than 20 percent of 200 macrophages stain positive for hemosiderin, a diagnosis of diffuse alveolar hemorrhage is usually made [
         <a href="#rid35">
          35,36
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4341.html" rel="external">
          "The diffuse alveolar hemorrhage syndromes", section on 'Bronchoalveolar lavage'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         CD 1a immunostaining identifies Langerhans cells; greater than 5 percent positivity enables a diagnosis of pulmonary Langerhans cell histiocytosis. (See
         <a class="medical medical_review" href="/z/d/html/4334.html" rel="external">
          "Pulmonary Langerhans cell histiocytosis", section on 'Flexible bronchoscopy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H214940662">
         <span class="h1">
          BERYLLIUM LYMPHOCYTE PROLIFERATION TEST
         </span>
         <span class="headingEndMark">
          —
         </span>
         When chronic beryllium disease is suspected, a beryllium lymphocyte proliferation test (BeLPT) can be performed on BAL fluid [
         <a href="#rid37">
          37
         </a>
         ]. The BeLPT requires more cells than are usually obtained during BAL, so four successive 60 mL lavages (total instilled volume of 240 mL) are performed. (See
         <a class="medical medical_review" href="/z/d/html/4367.html" rel="external">
          "Chronic beryllium disease (berylliosis)", section on 'Bronchoalveolar lavage'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h1">
          ADVERSE EFFECTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Flexible bronchoscopy with bronchoalveolar lavage is usually well tolerated. Rarely, BAL is complicated by fever, bronchoconstriction, transient hypoxemia or pneumothorax [
         <a href="#rid6">
          6,7,38
         </a>
         ]. However, pneumothorax is rare enough that postprocedure chest radiographs are usually not obtained unless the clinical status of the patient has deteriorated. (See
         <a class="medical medical_review" href="/z/d/html/4398.html" rel="external">
          "Flexible bronchoscopy in adults: Overview"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/105799.html" rel="external">
          "Flexible bronchoscopy in adults: Preparation, procedural technique, and complications", section on 'Complications'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1078320978">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/118793.html" rel="external">
          "Society guideline links: Interstitial lung disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bronchoalveolar lavage (BAL), performed during flexible bronchoscopy, is a minimally invasive technique for evaluating the immunologic, inflammatory, and infectious processes taking place at the alveolar level in diffuse lung disease. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         BAL is an excellent technique for evaluating opportunistic infections in immunocompromised hosts. (See
         <a class="local">
          'Patient selection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There are no absolute contraindications to the performance of BAL beyond those commonly associated with bronchoscopy  (
         <a class="graphic graphic_table graphicRef79205" href="/z/d/graphic/79205.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Patient selection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In localized disease, lavage of the involved segment is most likely to yield the best results. In diffuse disease, the right middle lobe or lingula is often chosen to optimize fluid recovery. (See
         <a class="local">
          'Technique'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The total volume of fluid to be instilled during BAL has not been standardized. We usually use two to three sequential aliquots of 40 to 60 mL each. (See
         <a class="local">
          'Fluid instillation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A number of steps are involved in the optimal processing and examination of BAL samples for total and differential cell counting. (See
         <a class="local">
          'Cell counting'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lymphocyte subpopulations (eg, CD3, CD4, CD8) can be assessed using immunofluorescent labeled monoclonal antibodies and either flow cytometry or hand counting of a slide from a cytocentrifuge specimen. (See
         <a class="local">
          'Lymphocyte subpopulations and immunohistochemistry'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Depending on the clinical situation, samples of BAL fluid may be sent for a variety of microbiologic analyses, including bacterial, viral and fungal cultures, and also direct fluorescent antigen (DFA) staining for Legionella or Pneumocystis jirovecii. (See
         <a class="local">
          'Microbiologic analysis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cytology of BAL fluid may be of use in the evaluation of some diffuse neoplasms affecting the lung (eg, bronchoalveolar carcinoma, lymphangitic carcinomatosis, and lymphoma) and in the evaluation of some diffuse lung diseases (eg, pulmonary alveolar proteinosis). (See
         <a class="local">
          'Cytologic analysis'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Meyer KC, Raghu G, Baughman RP, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 2012; 185:1004.
          </a>
         </li>
         <li class="breakAll">
          Costabel U, Guzman J. Bronchoalveolar lavage. In: Interstitial lung disease, 5th, Schwarz MI, King TE, Jr (Eds), People's Medical Publishing House-USA, Shelton, CT 2011. p.149.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stoller JK, Rankin JA, Reynolds HY. The impact of bronchoalveolar lavage cell analysis on clinicians' diagnostic reasoning about interstitial lung disease. Chest 1987; 92:839.
          </a>
         </li>
         <li class="breakAll">
          King, TE Jr. Interstitial lung disease. In: Feinsilver, SH, Fein, AM (Eds), Textbook of Bronchoscopy, Williams &amp; Wilkins, Baltimore, 1995, p. 185.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brownback KR, Simpson SQ. Association of bronchoalveolar lavage yield with chest computed tomography findings and symptoms in immunocompromised patients. Ann Thorac Med 2013; 8:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elston WJ, Whittaker AJ, Khan LN, et al. Safety of research bronchoscopy, biopsy and bronchoalveolar lavage in asthma. Eur Respir J 2004; 24:375.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baughman RP. Technical aspects of bronchoalveolar lavage: recommendations for a standard procedure. Semin Respir Crit Care Med 2007; 28:475.
          </a>
         </li>
         <li class="breakAll">
          King TE Jr. Handling and analysis of bronchoalveolar lavage specimens. In: Bronchoalveolar Lavage, Baughman RP (Ed), Year Book Medical Publishers, Philadelphia 1991. p.3.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Helmers RA, Dayton CS, Floerchinger C, Hunninghake GW. Bronchoalveolar lavage in interstitial lung disease: effect of volume of fluid infused. J Appl Physiol (1985) 1989; 67:1443.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Radhakrishna N, Farmer M, Steinfort DP, King P. A Comparison of Techniques for Optimal Performance of Bronchoalveolar Lavage. J Bronchology Interv Pulmonol 2015; 22:300.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seijo LM, Flandes J, Somiedo MV, et al. A Prospective Randomized Study Comparing Manual and Wall Suction in the Performance of Bronchoalveolar Lavage. Respiration 2016; 91:480.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shikano K, Abe M, Shiko Y, et al. What are the factors affecting the recovery rate of bronchoalveolar lavage fluid? Clin Respir J 2022; 16:142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Löfdahl JM, Cederlund K, Nathell L, et al. Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema. Eur Respir J 2005; 25:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kneidinger N, Warszawska J, Schenk P, et al. Storage of bronchoalveolar lavage fluid and accuracy of microbiologic diagnostics in the ICU: a prospective observational study. Crit Care 2013; 17:R135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goh NS, Veeraraghavan S, Desai SR, et al. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression. Arthritis Rheum 2007; 56:2005.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chou CW, Lin FC, Tung SM, et al. Diagnosis of pulmonary alveolar proteinosis: usefulness of papanicolaou-stained smears of bronchoalveolar lavage fluid. Arch Intern Med 2001; 161:562.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rottoli P, Magi B, Perari MG, et al. Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 2005; 5:1423.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fietta A, Bardoni A, Salvini R, et al. Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. Arthritis Res Ther 2006; 8:R160.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harbeck RJ. Immunophenotyping of bronchoalveolar lavage lymphocytes. Clin Diagn Lab Immunol 1998; 5:271.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Welker L, Jörres RA, Costabel U, Magnussen H. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J 2004; 24:1000.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith PA, Kohli LM, Wood KL, et al. Cytometric analysis of BAL T cells labeled with a standardized antibody cocktail correlates with immunohistochemical staining. Cytometry B Clin Cytom 2006; 70:170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smetana K Jr, Mericka O, Saeland S, et al. Diagnostic relevance of Langerin detection in cells from bronchoalveolar lavage of patients with pulmonary Langerhans cell histiocytosis, sarcoidosis and idiopathic pulmonary fibrosis. Virchows Arch 2004; 444:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Takizawa Y, Taniuchi N, Ghazizadeh M, et al. Bronchoalveolar lavage fluid analysis provides diagnostic information on pulmonary Langerhans cell histiocytosis. J Nippon Med Sch 2009; 76:84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baqir M, Vassallo R, Maldonado F, et al. Utility of bronchoscopy in pulmonary Langerhans cell histiocytosis. J Bronchology Interv Pulmonol 2013; 20:309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis 1990; 141:S169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heron M, Grutters JC, ten Dam-Molenkamp KM, et al. Bronchoalveolar lavage cell pattern from healthy human lung. Clin Exp Immunol 2012; 167:523.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karimi R, Tornling G, Grunewald J, et al. Cell recovery in bronchoalveolar lavage fluid in smokers is dependent on cumulative smoking history. PLoS One 2012; 7:e34232.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang GC, Wu CL, Pan SH, et al. The diagnosis of pneumonia in renal transplant recipients using invasive and noninvasive procedures. Chest 2004; 125:541.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin P, Chen Y, Su S, et al. Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients. BMC Infect Dis 2022; 22:416.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zompi S, Couderc LJ, Cadranel J, et al. Clonality analysis of alveolar B lymphocytes contributes to the diagnostic strategy in clinical suspicion of pulmonary lymphoma. Blood 2004; 103:3208.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Phadke SM, Chini BA, Patton D, Goyal RK. Relapsed non-Hodgkin's lymphoma diagnosed by flexible bronchoscopy. Pediatr Pulmonol 2002; 34:488.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poletti V, Romagna M, Allen KA, et al. Bronchoalveolar lavage in the diagnosis of disseminated lung tumors. Acta Cytol 1995; 39:472.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lower EE, Baughman RP. Pulmonary lymphangitic metastasis from breast cancer. Lymphocytic alveolitis is associated with favorable prognosis. Chest 1992; 102:1113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levy H, Horak DA, Lewis MI. The value of bronchial washings and bronchoalveolar lavage in the diagnosis of lymphangitic carcinomatosis. Chest 1988; 94:1028.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maldonado F, Parambil JG, Yi ES, et al. Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage. Eur Respir J 2009; 33:1361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Lassence A, Fleury-Feith J, Escudier E, et al. Alveolar hemorrhage. Diagnostic criteria and results in 194 immunocompromised hosts. Am J Respir Crit Care Med 1995; 151:157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heldt GH, Deubner DC. The beryllium bronchoalveolar lavage lymphocyte proliferation test: indicator of beryllium sensitization, inflammation or both? Inhal Toxicol 2015; 27:262.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jain P, Sandur S, Meli Y, et al. Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest 2004; 125:712.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 4303 Version 21.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22550210" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22550210" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3665598" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : The impact of bronchoalveolar lavage cell analysis on clinicians' diagnostic reasoning about interstitial lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3665598" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : The impact of bronchoalveolar lavage cell analysis on clinicians' diagnostic reasoning about interstitial lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23922610" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Association of bronchoalveolar lavage yield with chest computed tomography findings and symptoms in immunocompromised patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15358694" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Safety of research bronchoscopy, biopsy and bronchoalveolar lavage in asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17975775" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Technical aspects of bronchoalveolar lavage: recommendations for a standard procedure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17975775" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Technical aspects of bronchoalveolar lavage: recommendations for a standard procedure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2793747" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Bronchoalveolar lavage in interstitial lung disease: effect of volume of fluid infused.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26428510" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : A Comparison of Techniques for Optimal Performance of Bronchoalveolar Lavage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27241670" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : A Prospective Randomized Study Comparing Manual and Wall Suction in the Performance of Bronchoalveolar Lavage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34761545" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : What are the factors affecting the recovery rate of bronchoalveolar lavage fluid?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15684291" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23844796" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Storage of bronchoalveolar lavage fluid and accuracy of microbiologic diagnostics in the ICU: a prospective observational study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17530640" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11252115" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Diagnosis of pulmonary alveolar proteinosis: usefulness of papanicolaou-stained smears of bronchoalveolar lavage fluid.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15761959" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17044913" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9605975" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Immunophenotyping of bronchoalveolar lavage lymphocytes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15572545" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16568476" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Cytometric analysis of BAL T cells labeled with a standardized antibody cocktail correlates with immunohistochemical staining.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14722767" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Diagnostic relevance of Langerin detection in cells from bronchoalveolar lavage of patients with pulmonary Langerhans cell histiocytosis, sarcoidosis and idiopathic pulmonary fibrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19443993" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Bronchoalveolar lavage fluid analysis provides diagnostic information on pulmonary Langerhans cell histiocytosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24162113" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Utility of bronchoscopy in pulmonary Langerhans cell histiocytosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2186681" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. The BAL Cooperative Group Steering Committee.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22288596" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Bronchoalveolar lavage cell pattern from healthy human lung.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22479573" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Cell recovery in bronchoalveolar lavage fluid in smokers is dependent on cumulative smoking history.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14769736" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : The diagnosis of pneumonia in renal transplant recipients using invasive and noninvasive procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35488253" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15070704" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Clonality analysis of alveolar B lymphocytes contributes to the diagnostic strategy in clinical suspicion of pulmonary lymphoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12422348" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Relapsed non-Hodgkin's lymphoma diagnosed by flexible bronchoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7762334" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Bronchoalveolar lavage in the diagnosis of disseminated lung tumors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1327663" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Pulmonary lymphangitic metastasis from breast cancer. Lymphocytic alveolitis is associated with favorable prognosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3180853" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : The value of bronchial washings and bronchoalveolar lavage in the diagnosis of lymphangitic carcinomatosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19129275" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7812547" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Alveolar hemorrhage. Diagnostic criteria and results in 194 immunocompromised hosts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25942054" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : The beryllium bronchoalveolar lavage lymphocyte proliferation test: indicator of beryllium sensitization, inflammation or both?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14769756" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
